Stay Up-to-Date with Our Latest Posts

Skipping breakfast to shed a few pounds or squeezing all your meals into a six-hour window might sound like a modern health trend, but intermittent fasting has roots stretching back centuries. Today, it’s making headlines not just for weight loss, but for its potential to transform heart health, blood sugar, and more. Yet, behind the buzz, questions linger. Can everyone safely try intermittent fasting, or are there hidden risks that patients and clinicians need to consider?

Spotting the subtle signs of serious illness among the sea of everyday symptoms is one of the greatest challenges in general practice. For GPs, the pressure to distinguish between benign lower-GI complaints and those rare but critical red flags can feel relentless, especially when every decision could mean the difference between early intervention and missed opportunity.

Patients today expect more than just a phone line and a waiting room. They want seamless digital access, clear information, and joined-up care. As the NHS sets new standards for general practice from October 2025, the spotlight is firmly on how surgeries connect, communicate, and empower their communities.

A simple jab meant to prevent a painful rash could be quietly working wonders for your heart. While most people think of the shingles...

Every diabetes review brings a familiar number into focus: the HbA1c. For years, this single figure has shaped treatment plans, guided medication changes, and reassured both clinicians and patients that glucose control is on track.

Chickenpox has long been a familiar part of childhood in the UK, with many parents recalling the itchy spots and sleepless nights that...

When a single medicine underpins the stability of thousands of heart patients across the UK, even a brief disruption can send ripples...

Every day, GPs and pharmacists across the UK face a familiar challenge. Balancing the need for swift, expert advice with the pressure to keep patients out of lengthy referral queues.

Feeling your heart race before a big presentation or important meeting is all too familiar for many of us. For some, these physical symptoms of anxiety can be so overwhelming that daily life becomes a challenge.

Managing long-term conditions is one of the greatest challenges facing Integrated Care Boards today, with the pressure to deliver better...

Over 1.18 billion prescription items are written in the UK every year, yet up to half of patients do not take their medicines as intended. This silent gap between prescription and real-world use is costing not just billions of pounds, but also patient health, safety, and trust in the system.

GLP-1 prescriptions have increased by over 300 percent in the past year, leaving many GP practices overwhelmed by a relentless wave of letters and medication updates.

This year, that story reached a new milestone as The Medicines Management Team (TMMT) was recognised with the prestigious GHP Award for Excellence in Primary Care Pharmacy Services.

The NHS is setting the stage for a decade of transformation, with a bold 10-year plan that promises to reshape the delivery of healthcare across England.

More than one in four adults in England are now living with obesity, a figure that continues to climb each year despite countless diets, fitness trends, and public health campaigns.

Did you know that the overall number of pharmacists working in primary care networks has increased by more than a third in a year, yet many practice managers still struggle to unlock their team’s full potential.

Seven percent growth in contract funding is not just a headline—it signals a fundamental shift in how general practice will operate...

One in every five inhalers prescribed in the UK contributes significantly to the NHS’s carbon footprint, making respiratory care a surprising player in the climate conversation. With over 1.2 million people relying on inhalers for chronic obstructive pulmonary di

Unspent ARRS Funding How PCNs Can Maximise Critical Resources

Forty per cent of dermatophyte samples tested by the UK Health Security Agency in 2024 have shown resistance to terbinafine, the frontline antifungal treatment.